Top 50 Biotechnology VC Funds & Investors in Canada (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
39 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
Anges Quebec
VC Fund
|
24 | Canada, United States, Spain | Seed, Venture - Series Unknown, Angel | Software, Health Care, Artificial Intelligence | $376k–$8.5M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
23 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Biotechnology, Software | $13k–$8M |
|
BDC Venture Capital
VC Fund
|
22 | Canada, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $387k–$40M |
|
Lumira Ventures
VC Fund
|
20 | United States, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.9M–$88M |
|
Atlantic Canada Opportunities Agency
VC Fund
|
19 | Canada, United States, France | Grant, Debt Financing, Seed | Manufacturing, Software, Health Care | $25k–$2M |
|
SOSV SF & NY (Fka IndieBio)
VC Fund
|
17 | United States, United Kingdom, Canada | Seed, Pre-Seed, Convertible Note | Biotechnology, Health Care, Medical | $50k–$5M |
|
Innovacorp
VC Fund
|
17 | Canada, United States, Australia | Seed, Grant, Pre-Seed | Software, Health Care, Information Technology | $19k–$3.1M |
|
Fonds de solidarité FTQ
VC Fund
|
15 | Canada, United States, United Kingdom | Venture - Series Unknown, Series A, Series B | Manufacturing, Biotechnology, Health Care | $500k–$83M |
|
MaRS Investment Accelerator Fund
VC Fund
|
15 | Canada, United States | Seed, Pre-Seed, Series A | Software, Analytics, Artificial Intelligence | $375k–$14M |
|
FACIT
VC Fund
|
13 | Canada, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Medical Device | $1.5M–$35M |
|
BoxOne Ventures
VC Fund
|
13 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $281k–$115M |
|
Amplitude Venture Capital
VC Fund
|
13 | Canada, United States, Israel | Series B, Series A, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$142M |
|
Real Ventures
VC Fund
|
12 | Canada, United States, Australia | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $592k–$47M |
|
CTI Life Sciences Fund
VC Fund
|
10 | Canada, United States, Spain | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2M–$100M |
|
Golden Ventures
VC Fund
|
10 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$49M |
|
WUTIF
VC Fund
|
10 | Canada | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Biotechnology | $100k–$5.5M |
|
E-Fund
VC Fund
|
9 | Canada, China, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical, Medical Device | $279k–$43M |
|
StandUp Ventures
VC Fund
|
9 | Canada, United States | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $317k–$14M |
|
Business Development Bank of Canada
VC Fund
|
8 | Canada, United States, Nigeria | Venture - Series Unknown, Seed, Debt Financing | Software, Information Technology, Manufacturing | $100k–$78M |
|
Ontario Centres of Excellence
VC Fund
|
8 | Canada, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | |
|
VA Angels
VC Fund
|
8 | Canada, United States, India | Seed, Debt Financing, Venture - Series Unknown | Health Care, Software, Information Technology | $108k–$1.5M |
|
Pallasite Ventures
VC Fund
|
7 | Canada, United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $750k–$115M |
|
MEDTEQ+
VC Fund
|
7 | Canada, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $1.5M–$20M |
|
GreenSky Ventures
VC Fund
|
7 | Canada, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Artificial Intelligence | $708k–$12M |
|
Ramen Ventures
VC Fund
|
7 | Canada, United States | Seed, Pre-Seed, Angel | Software, Biotechnology, Health Care | $120k–$3.2M |
|
Golden Triangle Angel Network
VC Fund
|
7 | Canada, United States, China | Angel, Seed, Grant | Software, Health Care, Information Technology | $400k–$2.4M |
|
Ontario Centre of Innovation
VC Fund
|
7 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Software, Medical | $7.3k–$3.2M |
|
Radical Ventures
VC Fund
|
7 | United States, Canada, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $2M–$200M |
|
Accelerate Fund
VC Fund
|
7 | Canada, United States | Seed, Series A, Venture - Series Unknown | Software, Health Care, Information Technology | $360k–$13M |
|
BDC Capital’s Women in Technology Venture Fund
VC Fund
|
7 | Canada | Series A, Series B, Venture - Series Unknown | Software, Artificial Intelligence, SaaS | $2.6M–$200M |
|
OrbiMed
VC Fund
|
7 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9M–$160M |
|
Garage Capital
VC Fund
|
6 | Canada, United States, Israel | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $765k–$50M |
|
iGan Partners
VC Fund
|
6 | Canada, United States, Israel | Seed, Series A, Venture - Series Unknown | Health Care, Software, Medical | $500k–$17M |
|
Horizons Ventures
VC Fund
|
6 | United States, United Kingdom, Canada | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $1M–$110M |
|
Genesys Capital
VC Fund
|
6 | Canada, United States | Series A, Series B | Biotechnology, Health Care, Medical | $1.8M–$105M |
|
Panache Ventures
VC Fund
|
6 | Canada, United States, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $713k–$20M |
|
McRock Capital
VC Fund
|
6 | Canada, United States, Spain | Series A, Series B, Series C | Software, Manufacturing, Information Technology | $406k–$102M |
|
Zoic Capital
VC Fund
|
6 | United States, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $3M–$7.2M |
|
Desjardins Venture Capital
VC Fund
|
6 | Canada, United States | Venture - Series Unknown, Seed | Software, Manufacturing, Information Technology | $600k–$228M |
|
Hedgewood
VC Fund
|
6 | Canada, United States, India | Seed, Series A, Series B | Health Care, Software, E-Commerce | $500k–$120M |
|
BDC Healthcare Venture
VC Fund
|
6 | Canada, United States | Series A, Series B, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $4.2M–$68M |
|
Archangel Network of Funds
VC Fund
|
6 | Canada, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Medical Device | $10k–$19M |
|
Whitecap Venture Partners
VC Fund
|
6 | Canada, United States, Spain | Series A, Seed, Series B | Software, Health Care, Enterprise Software | $1.9M–$33M |
|
Natural Products Canada
VC Fund
|
5 | Canada | Grant, Seed, Series A | Biotechnology, Manufacturing, Food and Beverage | $70k–$4M |
|
Ontario Brain Institute
VC Fund
|
5 | Canada, United States, France | Grant, Seed, Venture - Series Unknown | Health Care, Medical Device, Medical | $38k–$14M |
|
Versant Ventures
VC Fund
|
5 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5M–$107M |
|
OS Fund
VC Fund
|
5 | United States, Canada | Series A, Seed, Series B | Biotechnology, Health Care, Health Diagnostics | $1.6M–$53M |
|
Sustainable Development Technology Canada
VC Fund
|
5 | Canada, United States, Brazil | Grant, Seed, Venture - Series Unknown | Manufacturing, Energy, Renewable Energy | $73k–$145M |
|
1517 Fund
VC Fund
|
5 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $240k–$41M |
| Access all 1151 VC funds in Canada Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 185
- Round size: Seed $803k–$3.3M; Angel $376k–$1.3M; Venture - Series Unknown $915k–$8.5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Scopia Surgical — Revolutionizing the operating room with our real-time artificial intelligence image processing technology. Scopia Surgical is a co-pilot for the human body, guiding surgeons with unprecedented accuracy and confidence.
- Galaxia — GALAXIA Mission Systems designs and develops intelligent satellites and edge computation platforms for space.
- Elisa Interactive — Elisa Interactive operates an asset-light, prompt-to-environment software model designed to lower technical entry barriers in user-generated gaming ecosystems. Its core application platform, Me-Z-Scene, utilizes artificial intelligence to automatically arrange existing asset kits into complex 3D worlds based on natural language inputs. Thecompany's value proposition centers on empowering casual gamers and amateur builders to deploy custom virtual spaces without requiring coding or digital design expertise.
MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organization through the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters. Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 87
- Round size: Seed $73k–$8M; Grant $13k–$100k; Pre-Seed $22k–$525k
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Grey Matter Neurosciences is a neurotechnology firm developing new medical devices and drug-device combinations to treat age-related brain illnesses like dementia.
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strong Canadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises. BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 585
- Round size: Seed $387k–$4.5M; Series A $2.7M–$21M; Venture - Series Unknown $1.4M–$40M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- WhatsNexx — Sujintoto adalah situs slot online yang memberikan pelayanan deposit yang sat set dan withdraw cepet selama 24 jam
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
- Gemin X Pharmaceuticals — Own Geminx.com today. Secure checkout and guided transfer support. No hidden fees.
Lumira Ventures, a later stage VC, partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 126
- Round size: Series A $2.9M–$85M; Series B $12M–$75M; Series C $16M–$88M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ...
The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians, we are building a stronger economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Grant, Debt Financing, Seed
- Geography: Canada, United States, France
Investor stats
- Total investments: 259
- Round size: Seed $25k–$2M; Grant $36k–$981k; Debt Financing $141k–$1.1M
- Lead/follow: 85% lead, 15% follow
Portfolio highlights
- Atlantic Beef Products — Atlantic Beef Products is a food production company that processes and offers beef products and provides a variety of recipes.
- Bluefield Seeding Solutions — Bluefield Seeding Solutions is an agtech company.
- Prince Edward Island Preserve Company — Prince Edward Island Preserve Company is a supplier of chocolates, ice cream, and pancakes.
IndieBio, re-named SOSV SF and SOSV NY in 2026, are two of SOSV’s three deeply resourced facilities for deep tech founders. The third is SOSV's HAX, in Newark, NJ. SOSV is the most active deep tech venture capital firm globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 676
- Round size: Seed $250k–$5M; Pre-Seed $50k–$525k; Convertible Note $150k–$950k
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- FluoSphera — Fluosphera better predicts the effects of molecules through animal-free microphysiological systems, helping you to discover more efficient drugs with less adverse side effects.
- Giraffe Bio — Giraffe Bio uses AI and biomolecules to optimize metal extraction, increase yield, and reduce environmental impact. Revolutionizing sustainable mining technology.
- Transition Metal Solutions — Transition harnesses wild microbial communities to recover copper and other critical metals from low-grade mining resources.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 184
- Round size: Seed $50k–$3.1M; Grant $25k–$100k; Pre-Seed $19k–$1.8M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright Breaks offers a workplace wellness solution to boost employee wellness, connection, and productivity with 7-minute live micro-breaks. Bright Breaks' wellness platform is designed to provide users with maximum benefits while requiring the least amount of effort. It only takes a few minutes per day to reduce stress and improve well-being.
- Planetary — Planetary develops ocean-based carbon removal technology to accelerate the natural carbon cycle. Planetary’s system purifies the mountains of alkaline rock waste left behind by large-scale mining operations, extracting the alkalinity from the rubble and putting it in the ocean, thus accelerating the carbon transition and rebalancing oceanchemistry.Planetary Technologies is on a mission to remove 1 billion tonnes of carbon dioxide from the atmosphere by 2035.
- Planetary — info@planetarytech.com
Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession, financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 288
- Round size: Series A $3.3M–$50M; Series B $7.5M–$83M; Venture - Series Unknown $500k–$40M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Premier Tech — Premier Tech has been focusing on skills development and recognition to constantly innovate, improve its operational excellence and deploy products and services that create value for its customers.
- KERIDIS BioÉnergie — KERIDIS BioÉnergie is engaged in the development of anaerobic digestation plants to produce renewable natural gas.
- Les Chantiers de Chibougamau ltée — Nordic Structures is the leading innovator in engineered wood products and mass timber construction. Its resource comes from responsibly managed lands within the regional boreal forest. Vertical integration, from forest to structure, bolstered by Nordic’s experienced design and development team, ensures consistent quality and unparalleled level ofservice.
Working with Ontario talent to develop World Class Companies Learn More
Show more...Investment focus
- Industry: Software, Analytics, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 180
- Round size: Seed $375k–$4M; Pre-Seed $409k–$1.5M; Series A $2.3M–$14M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $8.5M in 2014
Portfolio highlights
- thri5 — Thri5 develops software that connects retail data, people, and AI agents through a System of Actions. The platform monitors sales, margin, inventory, availability, and other operational data to identify exceptions and opportunities. It prioritizes signals, assigns ownership, coordinates workflows across retail teams, and supports execution through copilots and automation. The system also provides traceability and measures outcomes such as sales, margin, and inventory accuracy.
- Sprout Family — Sprout Family is a digital concierge service based in Canada, focusing on assisting individuals and families on their journey to build a family. The company offers a range of services tailored to personal family-building needs, including insurance and employee benefit funds. With a team of 10 employees, Sprout Family aims to provide comprehensivesupport and resources for Canadians looking to navigate the complexities of family planning and growth. The platform offers users the ability to access their Sprout benefits online, ensuring a seamless and supportive experience.
- Daedal Systems — Daedal Systems delivers instrumentation integration and contract development services for the clean tech nuclear sector. The company focuses on fusion energy and small modular reactor projects that require specialized plasma and reactor diagnostics. Its teams design and integrate diagnostic suites that provide parametric, temporal, and spatial coverage of plasma behavior to support measurement and validation. Offerings include neutron-hardened instrumentation, temperature sensing, and coolant analysis tailored for next-generation nuclear systems. Daedal Systems supports reactor developers by acting as an outsourced partner for diagnostics architecture so customers can concentrate on core power plant systems. The company also provides neutronics modeling and engineering services for both fission and fusion hardware design.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$8M; Series A $11M–$35M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Better care happens when the entire system is supported. Meet Hyivy's connected platform for pelvic care.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $1.3M–$9.5M; Pre-Seed $281k–$2M; Series A $744k–$115M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Thred — Something new is calling. Thred is coming soon.
Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 37
- Round size: Seed $7M–$18M; Series A $3.2M–$85M; Series B $35M–$142M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $193M in 2024
Portfolio highlights
- Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance, mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 303
- Round size: Seed $592k–$5M; Series A $3.7M–$24M; Series B $2.9M–$47M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $140M in 2017
Portfolio highlights
- Axya — Axya is a procurement execution platform for manufacturers. Use AI to run sourcing, purchase orders, and supplier follow-up alongside your ERP.
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
CTI Life Sciences Fund is a leading Canadian biotech venture capital firm with a global footprint.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 37
- Round size: Seed $2M–$31M; Series A $7.2M–$62M; Series B $10M–$100M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $100M in 2021
Portfolio highlights
- Find therapeutics — Finding hope by expanding the frontiers of therapy
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 200
- Round size: Seed $1.5M–$7.5M; Series A $6.8M–$32M; Series B $10M–$49M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $103M in 2024
Portfolio highlights
- Biossil — Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
- Powered by People — Powered by People is a values-driven wholesale platform featuring handmade, ethical products from makers in over 40 countries. Sign up now for pre-approved credit and net 60 terms at poweredbypeople.com
- Brodie Rec Leagues — Brodie Rec Leagues specializes in basketball tournaments, leagues, and training.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 77
- Round size: Seed $100k–$3.8M; Pre-Seed $279k–$1.5M; Venture - Series Unknown $200k–$5.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ViewsML — ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers. Their technology aims to improve patient outcomes by providing deeper insights into healthcare diagnostics. ViewsML is involved in developingimmunohistochemistry technology to streamline the diagnostic process and support research objectives efficiently.
- Carbonyx — Carbonyx transforms waste into carbon-negative advanced materials for industry.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities. The E-Fund involves specific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, China, United States
Investor stats
- Total investments: 62
- Round size: Seed $474k–$4.2M; Pre-Seed $279k–$1M; Venture - Series Unknown $913k–$43M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Qase — Qase helps law firms and legal referral organizations streamline referrals, automate intake and booking, and collect forwarding fees online.
- ViewsML — ViewsML leverages artificial intelligence to enhance virtual diagnostics and precision medicine. The company focuses on transforming spatial biology and translational research by utilizing virtual biomarkers. Their technology aims to improve patient outcomes by providing deeper insights into healthcare diagnostics. ViewsML is involved in developingimmunohistochemistry technology to streamline the diagnostic process and support research objectives efficiently.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
StandUp Ventures is a venture capital firm investing in female-founded companies in the B2B software and digital health sector. The firm is led by a team of experienced investors who have assembled a diverse advisory committee. The advisory committee is comprised of successful founders, venture investors, and other strategic mentors who will provide high-touch support to the entrepreneurs. StandUp Ventures catalyzes strong deal flow across Canada from its network and syndicate seed rounds with Angels and US VCs.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 52
- Round size: Seed $1.3M–$5M; Pre-Seed $317k–$2M; Series A $2.3M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $16M in 2019
Portfolio highlights
- Wygo — This is why you've gotta go outside.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Sprout Family — Sprout Family is a digital concierge service based in Canada, focusing on assisting individuals and families on their journey to build a family. The company offers a range of services tailored to personal family-building needs, including insurance and employee benefit funds. With a team of 10 employees, Sprout Family aims to provide comprehensivesupport and resources for Canadians looking to navigate the complexities of family planning and growth. The platform offers users the ability to access their Sprout benefits online, ensuring a seamless and supportive experience.
We are BDC, the bank for Canadian entrepreneurs. We support small and medium-sized businesses in all industries and at every stage of growth with money and advice. We are the Business Development Bank of Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Debt Financing
- Geography: Canada, United States, Nigeria
Investor stats
- Total investments: 362
- Round size: Seed $300k–$5M; Debt Financing $100k–$78M; Venture - Series Unknown $500k–$40M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Quadshift — Quadshift provides software solutions to thousands of businesses in a variety of vertical markets by acquiring and building great B2B software companies and holding them for the long term.
- Vimy Forge — Vimy Forge is a public-private partnership that aims to bridge the gap between defense procurement and Canadian innovation.
- TickTrade Systems — smartTrade Technologies is a leading global provider with multi-asset electronic trading platforms, helping buy-side & sell-side institutions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 150
- Lead/follow: no public data
Portfolio highlights
- Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
- Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
VA Angels, one of Canada’s leading angel investment groups, has member locations in Calgary, Edmonton, Kelowna and Winnipeg. Since 2003 they have done 57 deals worth $28.5 million and are one of the most active angel groups in Canada.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: Canada, United States, India
Investor stats
- Total investments: 113
- Round size: Seed $108k–$1.5M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Tonit — Connect with local riders. Discover hundreds of rides & events. Track & share your ride. Share photos & videos with the community.
- PLAYR.gg — Surf Giveaways is the #1 platform to run giveaways, sweepstakes, and contests for gamers. Grow your audience and build your community with giveaways now!
- eThor — Trusted By National Brands Trusted By National Brands Contactless In the age of COVID-19, it's more important than ever to provide your customers a safe way to pay. eThor offers a number of contactless payment options, from Apple Pay, Samsung Pay or other forms of
Pallasite Ventures is an agile venture capital firm providing early-stage financing for high-growth companies across a variety of industries.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 38
- Round size: Seed $750k–$5M; Series A $3.2M–$20M; Series B $14M–$115M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ionomr — Ionomr designs & manufactures advanced ion-exchange polymers & membranes that enable high performance and efficiency in applications like water & wastewater treatment, hydrogen production and advanced energy storage.
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 36
- Round size: Seed $1.5M–$4M; Series A $3M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- AI4Eyes — AI4Eyes offers an end-to-end AI software & data collection platform for fast, precise, and consistent ocular diagnostics, enabling clinicians to detect and improve eye health.
- NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
- Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies. GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSky Accelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs. GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 66
- Round size: Seed $708k–$3.3M; Series A $1.1M–$4.5M; Venture - Series Unknown $709k–$12M
- Lead/follow: 70% lead, 30% follow
- Last fund: Likely still investing — raised $117k in 2024
Portfolio highlights
- Derapi — Derapi is a universal API for distributed energy resource (DER) devices, including solar, battery storage, EV chargers, smart thermostats, heat pumps, and other behind-the-meter loads. Derapi unlocks the full value of DERs by removing bottlenecks related to data integration, reducing data infrastructure costs and speeding time to market for DERsoftware developers, DER device manufacturers, and others in the DER ecosystem.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 24
- Round size: Seed $600k–$3.2M; Angel $500k–$600k; Pre-Seed $120k–$1.5M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
- Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
Canada's leading early-stage investor community in Waterloo, funding innovative startups across tech sectors with a strong focus on impact and diversity.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Angel, Seed, Grant
- Geography: Canada, United States, China
Investor stats
- Total investments: 58
- Round size: Seed $500k–$2.4M; Angel $400k–$677k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- MesoMat — Boost fleet safety, fuel consumption, and operating costs real-time data from your tires.
- YOURIKA — AI-assisted education technology and student support
- Motion Gestures — Motion Gestures is a Canadian machine learning startup specializing in gesture recognition software. Motion Gestures specializes in machine learning-based gesture recognition software and was founded in Waterloo, Canada in 2016. The company aims to enable the rapid development and deployment of gesture-enabled interfaces for systems, devices, andapps. Its software supports advanced 2D and 3D gestures using motion, touch, and vision sensors and can be deployed on the cloud, gateway/hub, and embedded platforms. Developers are offered free licenses to the cloud SDK and can quickly create and test any gesture using their smartphones.
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 53
- Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $151k–$2.5M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Synmedix — Synmedix's mission is to provide new therapies that avoid the pitfalls of the past by avoiding resistance, addressing clinical gaps, and delivering solid economics in an equitable manner. It is a biotechnology company. For inquiries, email, telephone numbers, and physical addresses are available on their website.
- mDETECT Inc — mDETECT Inc. is a third-generation liquid biopsy company aimed at improving the clinical management of solid tumour cancers. Our blood tests provide a rapid assessment of cancer progression and response to therapy. Home https://static.wixstatic.com/media/a41d6b_4f3b85e3670a4bc2bb97fad03b256715%7Emv2.jpg mdetect
- blair health — Blair Health operates a virtual healthcare platform for women in midlife, beginning with menopause care. The platform provides online assessments, personalized treatment plans, video consultations with licensed healthcare providers, and follow-up support. Its programs also address urology and pelvic health, nutrition, healthy aging, and related midlife concerns. Users can track symptoms, access educational resources, communicate with providers, and participate in a community forum. Blair Health also offers employer plans that provide employees with assessments, consultations, health tracking, educational materials, and ongoing support.
Radical Ventures is an early-stage venture capital firm investing in entrepreneurs applying deep technology to transform massive industries. With a primary focus on artificial intelligence, Radical Ventures partners with entrepreneurs with global ambition to build enduring companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 138
- Round size: Seed $2M–$27M; Series A $7M–$83M; Series B $30M–$200M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $250M in 2026
Portfolio highlights
- Emerald AI — Emerald AI turns AI data centers into flexible grid assets, unlocking power capacity for AI while protecting grid reliability and energy affordability.
- Mantic — Mantic is a world-class technical team on a mission to solve the next AI grand challenge: predicting global events with superhuman accuracy, and deploying this capability to power radically improved decision-making in business and government.
- Crusoe — Crusoe provides next-gen AI infrastructure and cloud compute using an energy-first approach. Deploy AI workloads at scale with reliable performance and 24/7 support.
Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 62
- Round size: Seed $1M–$7.1M; Series A $961k–$13M; Venture - Series Unknown $360k–$1.5M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Helcim — Helcim is the easy and affordable solution for small and medium businesses accepting payments in-person or online.
- Cellar Insights — Maximize the value of your potato crop with smart remote monitoring. Monitor storage conditions and prevent crop loss with Cellar Insights.
- Fairly Staffing — The modern dental staffing platform. Connect your clinic with vetted dental hygienists and assistants, or find flexible temp dental jobs near you with Fairly.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BDC Capital Women in Technology (WIT) Fund is one of the world’s largest venture capital funds
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 35
- Round size: Series A $2.9M–$83M; Series B $13M–$200M; Venture - Series Unknown $2.6M–$42M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Waabi — Waabi operates as a self-driving technology start-up. Waabi is bringing the promise of self-driving closer to commercialization than ever before.
- Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.
- Eigen Innovations — Eigen combines imaging and AI to detect issues traditional vision systems miss, revolutionizing quality inspection.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 767
- Round size: Series A $9M–$116M; Series B $23M–$148M; Series C $19M–$160M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
Built by founders, for founders. Garage Capital helps best-in-class companies jump from garage to growth.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 146
- Round size: Seed $2M–$7.5M; Pre-Seed $765k–$3.6M; Series A $7.7M–$50M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Astrus — Astrus fully automates analog layout using AI without disrupting your workflow.
- Hestus — Hestus is an AI copilot inside Autodesk Fusion. It understands your design intent as you sketch and finishes the constraints, dimensions and cleanup, one keystroke at a time.
- Daedal Systems — Daedal Systems delivers instrumentation integration and contract development services for the clean tech nuclear sector. The company focuses on fusion energy and small modular reactor projects that require specialized plasma and reactor diagnostics. Its teams design and integrate diagnostic suites that provide parametric, temporal, and spatial coverage of plasma behavior to support measurement and validation. Offerings include neutron-hardened instrumentation, temperature sensing, and coolant analysis tailored for next-generation nuclear systems. Daedal Systems supports reactor developers by acting as an outsourced partner for diagnostics architecture so customers can concentrate on core power plant systems. The company also provides neutronics modeling and engineering services for both fission and fusion hardware design.
iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 50
- Round size: Seed $500k–$5.2M; Series A $3.9M–$17M; Venture - Series Unknown $10M–$14M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
- Adenocyte — Adenocyte. Early detection and prevention of pancreatic cancer.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 347
- Round size: Seed $1M–$10M; Series A $5.8M–$42M; Series B $10M–$110M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- HZO — HZO delivers customized protective nano and conformal coatings that safeguard electronics from the most demanding environments. It provides water protection solutions for electronics manufacturers by introducing a durable film to components during assembly. The company specializes in the fields of nanotechnology, waterproofing, electronics,nano-coating, full-submersion.It was founded in 2011 and headquartered in Morrisville, North Carolina.
- Jobspotting — Jobspotting is a recommendations engine that suggests relevant jobs to users based on their skills and experience. The engine is powered by Skills Graph and Semantic Analysis technology. The company was founded in 2013 in Berlin, Germany by ex-Googlers Hessam Lavi, Jan Backes and Manuel Holtz. Robin Haak joined the founding team in 2014 aftermeeting them through the Axel Springer Plug and Play Accelerator Programme, of which he was a co-founder. Jobspotting successfully acquired seed funding.
- Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
Genesys Capital is one of Canada's leading venture capital firms, investing in early-stage healthcare and biotechnology companies to drive innovation and improve lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Series A $1.8M–$21M; Series B $10M–$105M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $125M in 2016
Portfolio highlights
- Flosonics — Flosonics Medical is improving patient care through technology-enabled solutions and services that clinicians, and patients, love.
- Enspire DBS Therapy — Enspire DBS Therapy supports stroke recovery patients using deep brain stimulation with physical rehabilitation to restore motor function. Enspire DBS offers a robust method to mediate the effects of stimulation and stroke rehabilitation.
- Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
Canada's leading nationwide pre-seed venture fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 161
- Round size: Seed $912k–$6M; Pre-Seed $713k–$2.5M; Series A $6.3M–$20M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Biossil — Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
- Daedal Systems — Daedal Systems delivers instrumentation integration and contract development services for the clean tech nuclear sector. The company focuses on fusion energy and small modular reactor projects that require specialized plasma and reactor diagnostics. Its teams design and integrate diagnostic suites that provide parametric, temporal, and spatial coverage of plasma behavior to support measurement and validation. Offerings include neutron-hardened instrumentation, temperature sensing, and coolant analysis tailored for next-generation nuclear systems. Daedal Systems supports reactor developers by acting as an outsourced partner for diagnostics architecture so customers can concentrate on core power plant systems. The company also provides neutronics modeling and engineering services for both fission and fusion hardware design.
Since our inception in 2012, McRock has been widely recognized as the first investment firm focused exclusively on the Digital Industrial.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 50
- Round size: Series A $406k–$23M; Series B $665k–$102M; Series C $3M–$53M
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — raised $112M in 2019
Portfolio highlights
- Axya — Axya is a procurement execution platform for manufacturers. Use AI to run sourcing, purchase orders, and supplier follow-up alongside your ERP.
- OneLayer — OneLayer provides enterprise-grade security for private LTE/5G networks.
- Foundation EGI — The EGI platform from the Foundation is designed to speed up all phases of the product development cycle, from design and research to production and documentation, enabling engineers to create better products more quickly and effectively.
Zoic Capital is the only US-based venture firm focused on early-stage healthcare innovations at the intersection of life sciences and medical technology.Promising Scientific Advancements: We look for breakthroughs with the potential for broad IP and commercial-ready maturity. We invest in roadmaps that leverage a core innovation across manyapplications and industries.Focus on Life Sciences: We see the most exciting advancements coming from life sciences labs, becoming tools that maintain and treat our health. We look at both technologies that enable development and care delivery devices.We Follow the Numbers: We follow our gut, but we also reinforce each of our decisions with numbers. We believe that merging qualitative and quantitative analysis is the best way to make successful investment decisions.Mentored Capital: We have the skills, experience and network to help, working closely with select teams to transform research into high impact, market-ready products.Milestone-Based Investing: We craft unique deal structures for each portfolio company based on mutually defined milestones. We find this approach creates ongoing momuntum and sets us all up for success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 25
- Round size: Seed $3M–$4M; Series A $7.2M–$7.2M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $380k in 2023
Portfolio highlights
- Chromatan — ChromaTan is solving a major process bottleneck in therapeutic protein production while significantly lowering the cost of goods for biotech and contract manufacturing companies. Our CCTC platform provides an inexpensive column-free, continuous, and single-use solution that will replace large scale column chromatography processes used in biologicsmanufacturing. The platform has been through extensive beta testing with over a dozen of major biotech companies and has consistently shown a 5-15X increase in throughput at an equivalent or better product quality.
- ProbiusDx — At Probius, we are redefining biochemical analysis to drive research and advance healthcare.
- Trio Labs — The speed of metal additive manufacturing, the precision of CNC machining.
Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 166
- Round size: Seed $1M–$5.2M; Venture - Series Unknown $600k–$228M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $120M in 2018
Portfolio highlights
- Vention — Design and order custom industrial equipment in days. Fast and easy-to-use cloud CAD, loaded with modular parts, that ship next day.
- Inscora — Inscora is the cyber-insurability platform for MSPs and MSSPs. Assess risk, accurately measure client insurability, and unlock new revenue - without adding operational burden.
- Vosker — Vosker provides remote area monitoring tech enabling you to take things further
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Hedgewood is an investment firm active in venture capital, internet businesses, real estate, specialty finance, asset management, and private equity.
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, India
Investor stats
- Total investments: 112
- Round size: Seed $500k–$4.9M; Series A $7M–$17M; Series B $7.5M–$120M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- Unito — Unito is taking on a major problem that people are passionate about solving: they make it easier to collaborate across teams. They don't make users learn new tools and change the way they work. By connecting work management tools, they allow managers, cross-functional teams, departments, and entire companies to benefit from seamlesscollaboration and improved communication. The app syncs projects across a number of tools like Trello, Asana, JIRA, GitHub, Wrike, Zendesk & Hubspot. This is a hard problem of semantics, synchronization, and APIs.
- Vetster — Pet health starts with Vetster. Find and book veterinarians from across North America to provide excellent health care for your pet through video consults. Cats, dogs, reptiles, horses - all pets are welcome.
- Ready, Set, Food! — Ready. Set. Food! Our patented system is the safe, easy, and effective way to start early allergen introduction with you baby. Allergist-mom developed with all organic ingredients and zero added sugar.
BDC Healthcare Venture is a venture capital firm specializes in healthcare investments. The firm prefers to invest in the innovative therapeutics, medical technology, health technology, prevention, diagnostics, personalized treatment, mobile technologies and services, robotics, automation and disease management sectors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 19
- Round size: Series A $4.2M–$68M; Series B $4.7M–$30M; Venture - Series Unknown $23M–$60M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $278M in 2011
Portfolio highlights
- MEISSNER — Meissner leverages artificial intelligence to discover and develop next-generation superconducting materials.
- Repare Therapeutics — Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.
- PHEMI — The PHEMI Trustworthy Health DataLab is a unique, cloud-based, integrated big data management system that allows healthcare organizations to enhance innovation and generate value from healthcare data by simplifying the ingestion and de-identification of data with NSA/military-grade governance, privacy, and security built-in.Conventionalproducts simply lock down data, PHEMI goes further, solving privacy and security challenges and addressing the urgent need to secure, govern, curate, and control access to privacy-sensitive personal healthcare information (PHI). This improves data sharing and collaboration inside and outside of an enterprise—without compromising the privacy of sensitive information or increasing administrative burden.Built on privacy-by-design principles, the software gives researchers, scientists, and clinicians faster access to more information while ensuring that they only see data on a need-to-know basis. Responsible data sharing and a governance framework facilitate compliance with privacy regulations.PHEMI Trustworthy Health DataLab can scale to any size of organization, is easy to deploy and manage, connects to hundreds of data sources, and integrates with popular data science and business analysis tools.For more information, visit https://www.phemi.com/ and follow us on Twitter @PHEMISystems, Linkedin, Youtube, and Facebook
Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 69
- Round size: Seed $10k–$3.8M; Pre-Seed $700k–$1.6M; Venture - Series Unknown $1.6M–$19M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $10M in 2021
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- Streamforge — Streamforge helps companies find the most relevant creators for their games and products using the most sophisticated platform and technology on the market.
- TimeSmart.AI — Streamline your healthcare contracts and timesheet management system with TimeSmart.AI. Optimize contract lifecycles and stay compliant with the best tool for hospitals and healthcare organizations.
Whitecap Venture Partners is a Canadian-based Venture Capital fund investing in early stage technology companies. Whitecap is headquartered in Toronto and invests across Canada and the Northeastern US. Since Whitecap’s inception the early 1990s, Whitecap recognises the power of real collaboration between entrepreneurs and investors. This rapport enables them to provide significant value to companies along with strong returns across investment cycles. Whitecap specialises in Information & Communication Technologies (ICT) and Medical Technologies. Whitecap is continually searching for upcoming ventures to support as the next generation of exceptional enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Enterprise Software
- Stage:Series A, Seed, Series B
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 56
- Round size: Seed $1.9M–$5.4M; Series A $4.1M–$17M; Series B $8.9M–$33M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $110M in 2021
Portfolio highlights
- thri5 — Thri5 develops software that connects retail data, people, and AI agents through a System of Actions. The platform monitors sales, margin, inventory, availability, and other operational data to identify exceptions and opportunities. It prioritizes signals, assigns ownership, coordinates workflows across retail teams, and supports execution through copilots and automation. The system also provides traceability and measures outcomes such as sales, margin, and inventory accuracy.
- Branch Energy — A tech-powered, green energy provider focused on helping consumers reduce their energy bills and carbon footprints
- Future Fertility — Future Fertility is a fertility technology company focused on AI-enabled and non-invasive diagnostic solutions to optimize decision making throughout the IVF journey, maximizing the probability of positive outcomes in IVF workflows. The first product is an egg assessment software, which uniquely provides insights in egg quality and has thepotential to improve success rates of IVF, egg freezing and egg donation cycles.
Maximizing growth in naturally-derived products, technologies and services
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food and Beverage
- Stage:Grant, Seed, Series A
- Geography: Canada
Investor stats
- Total investments: 20
- Round size: Seed $500k–$3.3M; Grant $70k–$256k; Series A $911k–$4M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Scotiaderm — Scotiaderm is a company that manufactures a natural skin barrier formulation that protects against skin damage caused by exposure to urine, feces, sweat, and chaffing.
- BioNorth Solutions — Discover BioNorth Solutions, a leading green tech company offering microbial soil remediation, hydrocarbon cleanup, and plant growth biostimulants.
The Ontario Brain Institute works to establish Ontario as a world leader in brain research, commercialization and care.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Canada, United States, France
Investor stats
- Total investments: 57
- Round size: Seed $38k–$14M; Grant $50k–$100k
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Better Bionics — Better Bionics is a company developing affordable, high-function upper-limb prosthetics powered by AI-driven control systems.
- Prescia Health — Prescia Health is a digital health and cognitive neuroscience company.
- PragmaClin — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).
Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 333
- Round size: Series A $5M–$78M; Series B $12M–$105M; Series C $12M–$107M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $5M in 2024
Portfolio highlights
- Inari Medical — Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It hasdeveloped two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.The company was founded in 2011 and is headquartered in Irvine, California.
- Gate Bioscience — Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
We partner with future literate entrepreneurs who understand our unique time and place in history, with the ambition to author a better future for humanity.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Health Diagnostics
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 49
- Round size: Seed $1.6M–$6M; Series A $5M–$32M; Series B $12M–$53M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Arzeda — Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable.
- A-Alpha Bio — Measure more protein interactions
- Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.
Show more...Investment focus
- Industry: Manufacturing, Energy, Renewable Energy
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Canada, United States, Brazil
Investor stats
- Total investments: 277
- Round size: Seed $73k–$2.5M; Grant $825k–$7.3M; Venture - Series Unknown $2.5M–$145M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Niricson — Niricson develops an AI-based predictive analytics SaaS platform for infrastructure asset management. Its AUTOSPEX platform and DRONIC provide asset managers and civil engineers critical insights and multi-defect layer visualization for the current condition of their assets.
- Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
- Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
1517 Fund is an early stage venture capital fund that supports teams led by dropouts, deep-tech scientists & founders working outside of tracked institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 140
- Round size: Seed $600k–$7M; Pre-Seed $240k–$3M; Series A $7.6M–$41M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $3.1M in 2021
Portfolio highlights
- Deepgram — Deepgram helps enterprises unlock the potential of their audio data with custom-trained speech recognition for accuracy and scale. Deepgram's deep learning speech recognition system searches for keywords in transcripts by sound and text within audio and video files, used for transcribing calls, meetings, and voicemails for searchable notes,providing businesses with a fast, high accuracy speech-to-text on an easy-to-use API.The company was founded in 2015 and is headquartered in San Francisco, California.
- Positron — Positron makes purpose-built hardware to accelerate generative AI.
- Xona — Xona's Pulsar service is the first high-performance alternative to GPS designed to support the age of autonomy. Our constellation of smallsats will provide secure navigation and timing services with the resilience and accuracy needed to enable modern devices to operate safely in any conditions.
Biotechnology VC funding in Canada at a glance
Stats across 1.5k deals from 1.2k investors.
Access all 1151 VC funds in Canada Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1151 VC funds investing in Canada Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!